Diabetes Education and A1c Study (DEA1c)
Primary Purpose
Diabetes Mellitus, Type 2, Sleep
Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Sleep education
Diet only
Sponsored by

About this trial
This is an interventional treatment trial for Diabetes Mellitus, Type 2
Eligibility Criteria
Inclusion Criteria:
- Individuals with a diagnosis of type 2 diabetes who are patients at the Michigan State University (MSU) Endocrinology clinic,
- a diagnosis of overweight or obesity (Body Mass Index greater than or equal to 25.0 kg/m2),
- the most recent hemoglobin A1c value greater than or equal to 7.5%, and
- the ability to attend online program sessions.
Exclusion Criteria:
- significant psychiatric disorders,
- advanced medical conditions that require alterations to the MNT for DM2, e.g., advanced chronic kidney disease, and
- an inability to follow recommendations due to cognitive deficits.
Sites / Locations
- Michigan State University
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Other
Arm Label
Intervention
Control
Arm Description
Diet therapy plus sleep education
Diet therapy
Outcomes
Primary Outcome Measures
Hemoglobin A1c
Lab value
Secondary Outcome Measures
Body mass index
Calculated from height and weight
Sleep duration
FitBit outcomes data
Sleep quality
Pittsburgh Sleep Quality Index
Diabetes self-care
Diabetes Self-Management Questionnaire
Epworth Sleepiness Scale
Validated survey measuring excessive daytime sleepiness
Insomnia Severity Index
Validated survey measuring insomnia symptoms
Full Information
NCT ID
NCT04806685
First Posted
March 15, 2021
Last Updated
December 2, 2022
Sponsor
Michigan State University
Collaborators
Blue Cross Blue Shield Foundation of Michigan
1. Study Identification
Unique Protocol Identification Number
NCT04806685
Brief Title
Diabetes Education and A1c Study
Acronym
DEA1c
Official Title
Diabetes Education and A1c Study
Study Type
Interventional
2. Study Status
Record Verification Date
December 2022
Overall Recruitment Status
Completed
Study Start Date
March 15, 2021 (Actual)
Primary Completion Date
October 1, 2022 (Actual)
Study Completion Date
October 1, 2022 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Michigan State University
Collaborators
Blue Cross Blue Shield Foundation of Michigan
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
Sleep problems are associated with poor blood glucose control, but current diabetes self-management programs do not include sleep education. This study will randomize participants into two groups: one that receives sleep education and one that does not. The researchers expect both groups to experience reductions in blood glucose. The researchers hypothesize that individuals who receive sleep education as part of their diabetes self-management training will experience greater improvements in blood glucose control, as measured by hemoglobin A1c, compared to the control group.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Diabetes Mellitus, Type 2, Sleep
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Care ProviderOutcomes Assessor
Allocation
Randomized
Enrollment
22 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Intervention
Arm Type
Experimental
Arm Description
Diet therapy plus sleep education
Arm Title
Control
Arm Type
Other
Arm Description
Diet therapy
Intervention Type
Behavioral
Intervention Name(s)
Sleep education
Intervention Description
Medical nutrition therapy plus behavior-based sleep education intervention
Intervention Type
Behavioral
Intervention Name(s)
Diet only
Intervention Description
No sleep education
Primary Outcome Measure Information:
Title
Hemoglobin A1c
Description
Lab value
Time Frame
12 weeks
Secondary Outcome Measure Information:
Title
Body mass index
Description
Calculated from height and weight
Time Frame
12 weeks
Title
Sleep duration
Description
FitBit outcomes data
Time Frame
12 weeks
Title
Sleep quality
Description
Pittsburgh Sleep Quality Index
Time Frame
12 weeks
Title
Diabetes self-care
Description
Diabetes Self-Management Questionnaire
Time Frame
12 weeks
Title
Epworth Sleepiness Scale
Description
Validated survey measuring excessive daytime sleepiness
Time Frame
12 weeks
Title
Insomnia Severity Index
Description
Validated survey measuring insomnia symptoms
Time Frame
12 weeks
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Individuals with a diagnosis of type 2 diabetes who are patients at the Michigan State University (MSU) Endocrinology clinic,
a diagnosis of overweight or obesity (Body Mass Index greater than or equal to 25.0 kg/m2),
the most recent hemoglobin A1c value greater than or equal to 7.5%, and
the ability to attend online program sessions.
Exclusion Criteria:
significant psychiatric disorders,
advanced medical conditions that require alterations to the MNT for DM2, e.g., advanced chronic kidney disease, and
an inability to follow recommendations due to cognitive deficits.
Facility Information:
Facility Name
Michigan State University
City
East Lansing
State/Province
Michigan
ZIP/Postal Code
48824
Country
United States
12. IPD Sharing Statement
Learn more about this trial
Diabetes Education and A1c Study
We'll reach out to this number within 24 hrs